| | | | | | |
Company
| | Product Name
| | Indication(s)
| | Product Stage
|
BioCryst Pharmaceuticals, Inc.
| | Peramivir | | Influenza | | Pre-Registration |
Toyama Chemical Co., Ltd.
| | Favipiravir | | Influenza A and B Infections | | Pre-Registration |
Romark Laboratories, L.C.
| | Alinia | | Influenza | | Phase III |
Biota Pharmaceuticals, Inc.
| | Laninamivir | | Influenza A and B Infections | | Phase III |
Adamas Pharmaceuticals, Inc.
| | Oseltamivir | | Influenza | | Phase II |
Activaero GmbH
| | Acti-INSP-001 | | Influenza | | Phase II |
Far East Bio-Tec Co. Ltd
| | Apomivir | | Influenza | | Phase II |
Crucell N.V.
| | Diridavumab* | | Influenza A Infections | | Phase II |
Crucell N.V.
| | CR-8020* | | Influenza A Infections | | Phase II |
Genentech, Inc.
| | MHAA-4549A | | Influenza | | Phase II |
F. Hoffmann-La Roche Ltd.
| | RG-7745* | | Influenza A Infections | | Phase II |
Theraclone Sciences, Inc.
| | TCN-032* | | Influenza A Infections | | Phase II |
Vertex Pharmaceuticals Incorporated
| | VX-787 | | H5N1 Infection (Avian Influenza) | | Phase II |
Ansun Biopharma, Inc
| | Fludase | | Influenza | | Phase I |
Beech Tree Labs, Inc.
| | BTL-TML001 | | Influenza A and B Infections | | Phase I |
Celltrion, Inc.
| | CT-P27 | | Pandemic Influenza; Seasonal Influenza | | Phase I |
Fab’entech
| | Fabenflu | | H5N1 Infection (Avian Influenza) | | Phase I |
Autoimmune Technologies, LLC
| | Flufirvitide-3 | | Influenza | | Phase I |
Sarepta Therapeutics
| | Radavirsen | | Influenza | | Phase I |
